{"count": 3, "results": [{"_id": "16829188", "pmid": 16829188, "title": "Post-infarction treatment with simvastatin reduces myocardial no-reflow by opening of the KATP channel.", "journal": "Eur J Heart Fail", "authors": ["Yang YJ", "Zhao JL", "You SJ", "Wu YJ", "Jing ZC", "Gao RL", "Chen ZJ"], "date": "2007-01-01T00:00:00Z", "doi": "10.1016/j.ejheart.2006.04.013", "meta_date_publication": "2007 Jan", "meta_volume": "9", "meta_issue": "1", "meta_pages": "30-6", "score": 50069.336, "text_hl": "@<m>DISEASE_Post_Infectious_Disorders</m> @DISEASE_MESH:D000094025 @@@Post@@@-@DISEASE_Infarction @DISEASE_MESH:D007238 @@@infarction@@@ treatment with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ reduces @DISEASE_No_Reflow_Phenomenon @DISEASE_MESH:D054318 @@@myocardial no-reflow@@@ by opening of the KATP channel.", "citations": {"NLM": "Yang YJ, Zhao JL, You SJ, Wu YJ, Jing ZC, Gao RL, Chen ZJ. Post-infarction treatment with simvastatin reduces myocardial no-reflow by opening of the KATP channel. Eur J Heart Fail. 2007 Jan;9(1):30-6. PMID: 16829188", "BibTeX": "@article{16829188, title={Post-infarction treatment with simvastatin reduces myocardial no-reflow by opening of the KATP channel.}, author={Yang YJ and Zhao JL and You SJ and Wu YJ and Jing ZC and Gao RL and Chen ZJ}, journal={Eur J Heart Fail}, volume={9}, number={1}, pages={30-6}}"}}, {"_id": "28442532", "pmid": 28442532, "title": "Anti-inflammatory effects of simvastatin during the resolution phase of experimentally formed venous thrombi.", "journal": "J Investig Med", "authors": ["Feng Y", "Lei B", "Zhang F", "Niu L", "Zhang H", "Zhang M"], "date": "2017-08-01T00:00:00Z", "doi": "10.1136/jim-2017-000442", "meta_date_publication": "2017 Aug", "meta_volume": "65", "meta_issue": "6", "meta_pages": "999-1007", "score": 50053.06, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ targets anti-@DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ pathways during the resolution phase of a @DISEASE_Thrombosis @DISEASE_MESH:D013927 @@@thrombus@@@, providing a therapeutic potential in @DISEASE_Venous_Thrombosis @DISEASE_MESH:D020246 @@@DVT@@@ resolution and @<m>DISEASE_Post_Infectious_Disorders</m> @DISEASE_MESH:D000094025 @@@post-thrombotic syndrome@@@ prevention.", "citations": {"NLM": "Feng Y, Lei B, Zhang F, Niu L, Zhang H, Zhang M. Anti-inflammatory effects of simvastatin during the resolution phase of experimentally formed venous thrombi. J Investig Med. 2017 Aug;65(6):999-1007. PMID: 28442532", "BibTeX": "@article{28442532, title={Anti-inflammatory effects of simvastatin during the resolution phase of experimentally formed venous thrombi.}, author={Feng Y and Lei B and Zhang F and Niu L and Zhang H and Zhang M}, journal={J Investig Med}, volume={65}, number={6}, pages={999-1007}}"}}, {"_id": "28231942", "pmid": 28231942, "title": "Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention.", "journal": "J Am Coll Cardiol", "authors": ["Bohula EA", "Morrow DA", "Giugliano RP", "Blazing MA", "He P", "Park JG", "Murphy SA", "White JA", "Kesaniemi YA", "Pedersen TR", "Brady AJ", "Mitchel Y", "Cannon CP", "Braunwald E"], "date": "2017-02-28T00:00:00Z", "doi": "10.1016/j.jacc.2016.11.070", "meta_date_publication": "2017 Feb 28", "meta_volume": "69", "meta_issue": "8", "meta_pages": "911-921", "score": 50045.234, "text_hl": "The current study applied this tool prospectively to 17,717 @<m>DISEASE_Post_Infectious_Disorders</m> @DISEASE_MESH:D000094025 @@@post@@@-@DISEASE_Acute_Coronary_Syndrome @DISEASE_MESH:D054058 @@@ACS@@@ @SPECIES_9606 @@@patients@@@ randomized either to @CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@ezetimibe@@@ and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ or to placebo and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ in IMPROVE-IT (Improved Reduction of Outcomes: @CHEMICAL_Ezetimibe_Simvastatin_Drug_Combination @CHEMICAL_MESH:D000069499 @@@Vytorin@@@ Efficacy International Trial). ", "citations": {"NLM": "Bohula EA, Morrow DA, Giugliano RP, Blazing MA, He P, Park JG, Murphy SA, White JA, Kesaniemi YA, Pedersen TR, Brady AJ, Mitchel Y, Cannon CP, Braunwald E. Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention. J Am Coll Cardiol. 2017 Feb 28;69(8):911-921. PMID: 28231942", "BibTeX": "@article{28231942, title={Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention.}, author={Bohula EA and Morrow DA and Giugliano RP and Blazing MA and He P and Park JG and Murphy SA and White JA and Kesaniemi YA and Pedersen TR and Brady AJ and Mitchel Y and Cannon CP and Braunwald E}, journal={J Am Coll Cardiol}, volume={69}, number={8}, pages={911-921}}"}}]}